Clinic Payment Options as a Barrier to Accessing Medication-assisted Treatment for Opioid Use in Albuquerque, New Mexico

被引:2
作者
Rees, John [1 ]
Garcia, Gabriel [2 ]
机构
[1] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med Med Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
关键词
medication-assisted treatment; buprenorphine; New Mexico; Medicaid; insurance;
D O I
10.1097/ADT.0000000000000175
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objectives: For patients with opioid addiction seeking treatment, an effective option is Medication-assisted Treatment (MAT). In Albuquerque, the city with the greatest number of people who use opioids in New Mexico, the demand for MAT exceeds the number of patients receiving treatment. The authors hypothesized that a primary factor in patients' ability to access treatment is clinic payment options, rather than the traditionally cited availability of providers. Methods: The authors conducted a survey assessing payment methods and corresponding availability in MAT programs for 53 of Albuquerque's 70 providers. Results: The authors found a statistically significant (P<0.01) imbalance in treatment availability between insurance-accepting clinics (10.1% had >= 1 openings) and cash clinics (100% had >= 1 openings). Conclusions: These findings suggest that a lack of clinics accepting Medicaid and third party insurance may pose a significant treatment barrier. The authors thus conclude that more focus should be placed on increasing the number of clinicians and clinics accepting insurance.
引用
收藏
页码:246 / 248
页数:3
相关论文
共 7 条
  • [1] Jacobs H., 2018, BUSINESS INSIDER
  • [2] National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
    Jones, Christopher M.
    Campopiano, Melinda
    Baldwin, Grant
    McCance-Katz, Elinore
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (08) : E55 - E63
  • [3] Adoption and Implementation of Medications in Addiction Treatment Programs
    Knudsen, Hannah K.
    Abraham, Amanda J.
    Roman, Paul M.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2011, 5 (01) : 21 - 27
  • [4] Lee M, 2017, US NEWS WORLD REPORT
  • [5] Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
    Parran, T. V.
    Adelman, C. A.
    Merkin, B.
    Pagano, M. E.
    Defranco, R.
    Ionescu, R. A.
    Mace, A. G.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2010, 106 (01) : 56 - 60
  • [6] Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol
    Shah, Nina G.
    Lathrop, Sarah L.
    Reichard, R. Ross
    Landen, Michael G.
    [J]. ADDICTION, 2008, 103 (01) : 126 - 136
  • [7] Zur J., 2018, OPIOID EPIDEMIC MED